Medtronic ROA 2006-2019 | MDT

Current and historical return on assets (ROA) values for Medtronic (MDT) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Medtronic ROA for the three months ending January 31, 2019 was 7.77%.
Medtronic ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2019-01-31 $4.92B $88.73B 5.50%
2018-10-31 $2.26B $88.15B 2.48%
2018-07-31 $3.16B $89.72B 3.41%
2018-04-30 $3.10B $91.39B 3.25%
2018-01-31 $2.81B $95.80B 2.88%
2017-10-31 $5.02B $94.46B 5.12%
2017-07-31 $4.12B $100.25B 4.16%
2017-04-30 $4.03B $99.86B 4.08%
2017-01-31 $3.97B $97.58B 4.03%
2016-10-31 $4.24B $98.41B 4.25%
2016-07-31 $3.65B $98.60B 3.59%
2016-04-30 $3.54B $99.64B 3.44%
2016-01-31 $2.43B $102.71B 2.32%
2015-10-31 $2.32B $104.95B 2.49%
2015-07-31 $2.62B $104.63B 3.44%
2015-04-30 $2.68B $106.69B 4.49%
2015-01-31 $3.12B $55.23B 7.37%
2014-10-31 $2.91B $38.78B 7.68%
2014-07-31 $2.98B $37.55B 8.00%
2014-04-30 $3.07B $37.94B 8.36%
2014-01-31 $3.59B $37.23B 9.99%
2013-10-31 $3.81B $36.47B 10.79%
2013-07-31 $3.56B $34.97B 10.25%
2013-04-30 $3.47B $34.90B 10.12%
2013-01-31 $3.49B $34.95B 10.34%
2012-10-31 $3.44B $33.96B 10.41%
2012-07-31 $3.66B $33.25B 11.28%
2012-04-30 $3.62B $32.82B 11.34%
2012-01-31 $3.40B $31.91B 10.85%
2011-10-31 $3.39B $31.75B 10.93%
2011-07-31 $3.09B $31.09B 10.15%
2011-04-30 $3.10B $30.68B 10.39%
2011-01-31 $3.28B $30.60B 11.23%
2010-10-31 $3.18B $29.31B 11.44%
2010-07-31 $3.48B $28.66B 13.12%
2010-04-30 $3.10B $28.09B 12.26%
2010-01-31 $2.25B $25.17B 9.30%
2009-10-31 $2.11B $24.28B 8.97%
2009-07-31 $1.79B $23.57B 7.79%
2009-04-30 $2.07B $23.59B 9.09%
2009-01-31 $2.69B $22.76B 11.98%
2008-10-31 $2.07B $22.03B 9.36%
2008-07-31 $2.19B $22.73B 10.06%
2008-04-30 $2.14B $22.20B 10.20%
2008-01-31 $2.23B $21.41B 10.99%
2007-10-31 $2.86B $20.59B 14.44%
2007-07-31 $2.88B $19.66B 14.83%
2007-04-30 $2.80B $19.51B 14.34%
2007-01-31 $2.73B $19.57B 13.94%
2006-10-31 $2.69B $18.90B 13.95%
2006-07-31 $2.83B $20.18B 14.88%
2006-04-30 $2.55B $19.67B 14.02%
2006-01-31 $2.00B $18.34B 11.50%
2005-10-31 $1.88B $17.77B 11.21%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $124.635B $29.953B
Medtronic Public Limited Company, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $132.673B 26.23
Stryker (SYK) United States $69.927B 25.67
Boston Scientific (BSX) United States $55.591B 27.10
Baxter (BAX) United States $39.448B 24.31
Zimmer Biomet Holdings (ZBH) United States $25.289B 16.23
Smith & Nephew SNATS (SNN) United Kingdom $16.755B 0.00
ResMed (RMD) United States $14.297B 27.11
Canopy Growth (CGC) Canada $10.742B 0.00
Bio-Rad Laboratories (BIO) United States $8.172B 52.25
Aurora Cannabis (ACB) Canada $7.060B 50.50
Hill-Rom Holdings (HRC) United States $6.958B 21.52
Perrigo (PRGO) Ireland $6.649B 10.09
ICU Medical (ICUI) United States $5.184B 28.88
Insulet (PODD) United States $5.071B 0.00
Haemonetics (HAE) United States $4.540B 40.28
GW Pharmaceuticals (GWPH) United Kingdom $4.400B 0.00
Agios Pharmaceuticals (AGIO) United States $3.380B 0.00
Hutchison China MediTech (HCM) China $3.329B 0.00
Neogen (NEOG) United States $3.267B 50.18
NuVasive (NUVA) United States $2.850B 24.96
Quidel (QDEL) United States $2.761B 24.91
National Vision Holdings (EYE) United States $2.637B 51.01
Aphria (APHA) $2.539B 112.78
NxStage Medical (NXTM) United States $2.000B 0.00
AtriCure (ATRC) United States $1.274B 0.00
HEXO (HEXO) $1.242B 0.00
Cardiovascular Systems (CSII) United States $1.240B 890.25
Phibro Animal Health (PAHC) United States $1.220B 17.53
VAREX IMAGING (VREX) United States $1.212B 23.73
MacroGenics (MGNX) United States $0.939B 0.00
Cerus (CERS) United States $0.904B 0.00
PetIQ (PETQ) United States $0.867B 22.47
Lantheus Holdings (LNTH) United States $0.847B 22.95
Surmodics (SRDX) United States $0.785B 114.20
Meridian Bioscience (VIVO) United States $0.733B 21.85
NanoString Technologies (NSTG) United States $0.721B 0.00
OraSure Technologies (OSUR) United States $0.720B 31.76
Omeros (OMER) United States $0.719B 0.00
Evolus (EOLS) United States $0.705B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.647B 20.75
LeMaitre Vascular (LMAT) United States $0.603B 28.76
Quanterix (QTRX) United States $0.518B 0.00
Insys Therapeutics (INSY) United States $0.426B 0.00
Owens & Minor (OMI) United States $0.408B 5.65
TG Therapeutics (TGTX) United States $0.398B 0.00
Utah Medical Products (UTMD) United States $0.339B 21.99
BioLife Solutions (BLFS) United States $0.329B 445.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.294B 0.00
Vapotherm (VAPO) United States $0.288B 0.00
Bovie Medical (APYX) United States $0.282B 0.00
Rockwell Medical (RMTI) United States $0.262B 0.00
Cytosorbents (CTSO) United States $0.256B 0.00
Zynex (ZYXI) United States $0.174B 16.84
Fonar (FONR) United States $0.144B 7.70
Surface Oncology (SURF) United States $0.140B 0.00
Chembio Diagnostics (CEMI) United States $0.112B 0.00
Chimerix (CMRX) United States $0.100B 0.00
United-Guardian (UG) United States $0.090B 18.77
Female Health (VERU) United States $0.084B 0.00
InfuSystems Holdings (INFU) United States $0.078B 0.00
CAS Medical Systems (CASM) United States $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.066B 18.20
Conatus Pharmaceuticals (CNAT) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Neurotrope (NTRP) United States $0.034B 0.00
Senestech (SNES) United States $0.021B 0.00
Myomo (MYO) United States $0.016B 0.00
Akers Biosciences Inc (AKER) United States $0.014B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Capricor Therapeutics (CAPR) United States $0.013B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 14.14